Cargando…
MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome
BACKGROUND: To diagnose multiple sclerosis (MS), evidence for dissemination in space and time is required. There is no clear definition on how symptoms and signs of a patient indicate clinical dissemination in space. To provide a uniform approach on this subject, a clinical classification system was...
Autores principales: | Nielsen, Jessica M, Pohl, Christoph, Polman, Chris H, Barkhof, Frederik, Freedman, Mark S, Edan, Gilles, Miller, David H, Bauer, Lars, Sandbrink, Rupert, Kappos, Ludwig, Uitdehaag, Bernard MJ |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702360/ https://www.ncbi.nlm.nih.gov/pubmed/19457248 http://dx.doi.org/10.1186/1471-2377-9-19 |
Ejemplares similares
-
Correction: Prognostic implications of a carefully performed neurological assessment in patients with a first event suggestive of multiple sclerosis
por: Nielsen, Jessica M, et al.
Publicado: (2011) -
Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis
por: Penner, Iris-Katharina, et al.
Publicado: (2012) -
Molecular mechanism underlying the impact of vitamin D on disease activity of MS
por: Munger, Kassandra L, et al.
Publicado: (2014) -
The 11-year long-term follow-up study from the randomized BENEFIT CIS trial
por: Kappos, Ludwig, et al.
Publicado: (2016) -
Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes
por: De Stefano, Nicola, et al.
Publicado: (2014)